Tropomodulin 1 controls erythroblast enucleation via regulation of F-actin in the enucleosome

Mammalian erythroblast enucleation is a rapid cellular process (<10 minutes in cultured erythroblasts^1,2 ) involving nuclear polarization to one side of the cell, membrane protein sorting to remove unwanted membrane proteins from the nascent reticulocyte, nuclear translocation and expulsion, followed finally by separation of the pyrenocyte (expelled nucleus) from the nascent reticulocyte.^3-7  Many genes have been linked directly or indirectly to enucleation,^8,9  from transcription factors (eg, KLF1¹⁰ ) to signaling molecules (eg, Rac GTPases^11-14 ), structural proteins (eg, mDia2,¹⁴  dematin¹⁵ ), molecular motors (eg, dynein^16,17  and nonmuscle myosin IIB [NMIIB]^2,11,12 ), and endocytic pathway components (eg, EPS15, clathrin^18,19 ), converging on a model in which enucleation is proposed to be analogous to asymmetric cell division, with microtubules important for cell polarization and nuclear movement, and F-actin assembly into an actomyosin contractile ring driving nuclear expulsion. Local activation of phosphoinositide-3-kinase near the microtubule-organizing center regulates cell polarity and nuclear movement to the opposing side of the erythroblast.²  Nuclear polarization and movement also require degradation of dynein microtubule motors by Trim58, a ubiquitin ligase upregulated during terminal erythroid differentiation.¹⁶  F-actin assembly and actomyosin contractile activity are important for nuclear expulsion, based on impaired enucleation by cytochalasin D inhibition of actin assembly^2,11,20  and by blebbistatin inhibition of myosin II in cultured mouse and human erythroblasts.^2,12  However, the subcellular location of F-actin and NMIIB assembly and force production with respect to initiation, progression, and completion of the process of nuclear expulsion are not clearly understood.

Key regulators of F-actin assembly and stability in postmitotic, differentiated cells are tropomodulins (Tmods), which bind to tropomyosin and cap the pointed (slow-growing) ends of F-actin, regulating filament length and stability in contractile structures as well as in the membrane skeleton.^21,22 Tmod1 is the sole member of the Tmod family present in mouse and human erythrocytes, where it caps the pointed ends of the short F-actins in the membrane skeleton.²³  Loss of Tmod1 in mice results in a mild compensated hemolytic anemia with variable F-actin lengths and a defective spectrin-actin lattice.²⁴  However, Tmod3 is expressed during erythroid differentiation²⁵  and is upregulated in Tmod1^−/− mouse erythrocytes, providing partial compensation and accounting for the mild anemia.²⁴  By contrast, Tmod3^−/− mice are embryonic lethal with anemia due to impaired fetal liver (FL) erythropoiesis with defective macrophage-erythroblast interactions and defective enucleation, but tropomodulin 1 (Tmod1) levels do not increase and Tmod1 does not compensate for loss of Tmod3.²⁵ 

Here, we used high-resolution confocal fluorescence microscopy to study erythroblast morphology and F-actin rearrangements during the progression of mammalian enucleation in vivo, finding that some but not all of the structural rearrangements of F-actin and morphological events of enucleation are conserved between primary mouse and human erythroblasts. We found that primary mouse erythroblasts form a cell surface constriction (neck) through which the nucleus passes, acquiring a dumbbell-shaped morphology, while primary human bone marrow erythroblasts do not form a cell surface constriction, and nuclei retain their spherical morphology throughout the process of expulsion. Notably, during the initiation and progression of nuclear expulsion, F-actin fails to form a continuous contractile ring at the membrane sorting boundary between the emerging nucleus and the nascent reticulocyte in human or mouse erythroblasts. Instead, a different F-actin population (the “enucleosome”) forms in polarized erythroblasts, defined by a large F-actin spot or collection of smaller spots in the cytoplasm that follows the rear of the translocating nucleus. This F-actin population is associated with NMIIB and Tmod1, but not mDia2, Arp3, or Tmod3. Using in vivo and in vitro models, we found that Tmod1 plays an important role in enucleation of human and mouse erythroblasts by regulating F-actin in the enucleosome at the rear of the nucleus. Altogether, these observations bring novel insights into F-actin rearrangements during enucleation and indicate the need for a reexamination of the cytoskeleton contribution to the forces required for nuclear expulsion in this critical process.

E13-E15.5 embryos from wild-type or Tmod1^−/− mice on C57Bl6/J background were used to obtain FL erythroblasts. Bone marrow erythroblasts were from 2-month-old adult C57Bl6/J mice. Splenic erythroblasts were from adult C57Bl6/J mice phlebotomized on days 1, 2, and 3, harvesting spleens on day 4. All experiments were performed according to National Institutes of Health animal care guidelines, as approved and enforced by Institutional Animal Care and Use Committee at The Scripps Research Institute.

Mouse FLs, bone marrow, or spleens were dissociated into phosphate-buffered saline by gentle trituration using a cutoff P200 tip, followed by 4 hours or overnight fixation in 4% paraformaldehyde in phosphate-buffered saline at room temperature, and immunostaining as described.²⁵  All studies involving human samples were conducted in accordance with the Declaration of Helsinki and under institutional review board approval of the Northwell Health System.

CD34⁺ isolation from cord blood and differentiation toward the erythroid lineage were carried out as previously described.²⁶ 

Images were acquired on a Bio-Rad Radiance 2100 or a Zeiss LSM 780 laser scanning confocal microscope with a 100×/1.4 numerical aperture objective, zoom 2 (LSM 780) or 3 (Radiance 2100). For Z-stacks, the step size was 0.3 µm, and sufficient Z-steps were collected to image the entire cell (usually between 17 and 25 steps). Images and 3-dimensional (3D) animations were processed and analyzed using Volocity 6.1.1 and Adobe Photoshop.

Statistical analysis was performed using Prism 7.0 (GraphPad Software, Inc). Data are expressed as mean ± standard error of the mean. Significance was defined as P < .05.

Additional methods and details are described in supplemental Methods, available on the Blood Web site.

The actin cytoskeleton is critical for efficient erythroblast enucleation,^{11,12,14,20,25,27,28}  but F-actin organization with respect to the morphological progression of enucleation is not understood. Examination of F-actin in mouse FL erythroblasts revealed that nonpolarized erythroblasts exhibit dispersed F-actin fibrils and foci around the periphery of the nucleus (Figure 1A), whereas polarized erythroblasts have a bright spot of F-actin in the cytoplasm on the side of the nucleus opposite its membrane point of contact (Figure 1A arrows). A small F-actin cap is also seen at the site of nuclear contact with the membrane (Figure 1A open arrowhead). Once a nuclear protrusion forms, a membrane protein-sorting boundary appears with low Ter119 signal surrounding the nuclear protrusion in comparison with the remainder of the cell membrane (Figure 1A dashed lines). At this sorting boundary, the enucleating erythroblasts develop a prominent cell surface constriction with bright F-actin foci connecting to small F-actin cables surrounding the protruding nuclear lobe, resembling an F-actin “basket” cradling the nuclear protrusion (Figure 1A closed arrowheads; supplemental movies 1-3). A bright spot of cytoplasmic F-actin remains at the rear of the nucleus, traveling with the nucleus throughout expulsion, approaching the F-actin foci at the cell constriction zone late in enucleation (Figure 1A arrows). The resulting Ter119-positive reticulocyte and Ter119-negative pyrenocyte both contain a bright F-actin spot once they have separated from one another (Figure 1A arrows). Similar F-actin rearrangements and morphological features are evident in erythroblasts prepared without cytospinning, or imaged with structured illumination microscopy (supplemental Figure 1). Mouse bone marrow erythroblasts and splenic erythroblasts from phlebotomized mice also show similar morphologies and patterns of F-actin during enucleation (supplemental Figure 2). Thus, F-actin rearrangements are coordinated with the striking morphological changes observed during erythroblast polarization and nuclear expulsion.

F-actin at the cell surface constriction of mouse erythroblasts is associated with a prominent nuclear constriction, resulting in a dumbbell-shaped nuclear morphology (Figure 1A). This morphology is also observed in histological sections and transmission electron micrographs of mouse FLs (supplemental Figure 3).^2,29-31  We performed morphometric analyses of cell and nuclear dimensions to obtain insights into the nature of the cell surface and nuclear constrictions. The diameter of the cell surface constriction can be approximated as a parabolic function of the extent of nuclear protrusion (Figure 1B-C), indicating that the opening through which the nucleus passes is initially small, then enlarges, and finally shrinks as the nucleus is expelled. The length of the nucleus along its long axis (ie, in the direction of expulsion) also increases and then decreases (Figure 1D), indicating that elongation and shortening of the nucleus occurs coincidently with widening and narrowing of the constriction, respectively (Figure 1E). Even at its greatest diameter, the maximum diameter of the opening is smaller than that of the round condensed nucleus in a polarized erythroblast, providing a necessity for nuclear deformation during expulsion (supplemental Table 1). Notably, regardless of the extent of nuclear expulsion, nuclear diameter occupies a constant fraction (∼75%) of the cell surface constriction diameter (supplemental Table 1), implying that the remaining ∼25% of the cell surface constriction diameter is occupied by cytoplasmic and/or cytoskeletal components, such as F-actin (Figure 1A). The biphasic variations in diameter of the constriction neck during nuclear expulsion are distinct from cytokinesis, where the membrane constriction site progressively decreases in diameter.³² 

To further evaluate F-actin organization at the cell surface constriction, we visualized F-actin in enucleating erythroblasts using 3D reconstructions of confocal Z-stacks, reorienting the cells 90° to view the neck circumference (Figure 1F). In mouse FL erythroblasts early in the process of nuclear expulsion, characterized by a partially protruding nuclear lobe and small neck diameter, F-actin nearly surrounds the nucleus at the cell surface constriction, although the accumulation of F-actin is not uniform around the constriction (Figure 1Fa,a′). In erythroblasts more advanced in the process with a wider cell surface constriction, F-actin fails to completely surround the constriction, exhibiting small gaps and/or large F-actin–free regions (Figure 1Fc,c′-d,d′; supplemental Figure 4A). The discontinuous F-actin at the constriction site in enucleating FL erythroblasts contrasts with dividing FL cells in which a continuous F-actin ring can be observed at the constriction site during cytokinesis (supplemental Figure 4B). Only at the final stage of nuclear expulsion, when the nucleus is nearly completely expelled, and separation of the reticulocyte from the pyrenocyte is imminent, is a continuous F-actin ring evident at the constriction site (Figure 1Fe,e′-f,f′), as previously observed.^11,20  By contrast, earlier stages of nuclear expulsion through the erythroblast neck do not involve a continuous F-actin contractile ring (Figure 1Fc,c′-d,d′).

Bipolar myosin filaments comprising NMIIB are proposed to interact with F-actin to produce force for nuclear expulsion.^12,33  Indeed, NMIIB colocalizes with the bright F-actin spot at the rear of the translocating nucleus in polarized and enucleating erythroblasts, and to a lesser extent with the F-actin spots in the neck region, but similar to F-actin, NMIIB appears in discrete foci and does not form a continuous ring (Figure 2A arrows and arrowheads). Moreover, mDia2, which nucleates F-actin assembly into the contractile ring in dividing cells,³⁴  is not detected in any of the F-actin foci in polarized or enucleating mouse erythroblasts, even late in the process when the reticulocyte separates from the pyrenocyte (supplemental Figure 5A). By contrast, mDia2 staining is clearly evident in the contractile ring of dividing erythroblasts, as expected²⁸  (supplemental Figure 5A). Arp3, another actin nucleator,³⁵  is also not present in the F-actin foci of polarized or enucleating erythroblasts (supplemental Figure 5B).

Next, we examined the F-actin pointed-end capping proteins,³⁶  Tmod1 and Tmod3.²⁵  Although Tmod3 is important for enucleation in the mouse FL in vivo,²⁵  Tmod3 does not colocalize with any of the F-actin spots at the rear of the nucleus or at the neck, at any stage of erythroblast polarization or enucleation (supplemental Figure 6B). In contrast, Tmod1 is enriched at the bright cytoplasmic F-actin spots in polarized and enucleating erythroblasts, and at the cell surface constriction site in enucleating erythroblasts (Figure 2B arrows). The association of NMIIB and Tmod1 with these F-actin foci during nuclear expulsion suggests that they may be key participants in F-actin rearrangements associated with the cell and nuclear shape changes during enucleation in mouse erythroblasts, albeit not in a contractile ring as previously hypothesized.^3,11 

To determine whether the changes in F-actin organization, cell, and nuclear morphology observed during mouse erythroblast enucleation are conserved in human erythroblast enucleation, we visualized human bone marrow erythroblasts harvested directly from normal donors. Human bone marrow erythroblast enucleation is also characterized by a bright F-actin spot or spots in polarized cells, which follow the rear of the translocating nucleus throughout expulsion and are retained in the nascent reticulocyte (Figure 3A arrows; supplemental movies 4 and 5), similar to mouse FL and bone marrow erythroblast enucleation (Figure 1A; supplemental Figures 1-2). The cytoplasmic F-actin spots in enucleating human erythroblasts are associated with NMIIB and Tmod1, similar to mouse (Figure 4A-B). However, unlike mouse erythroblasts, which show robust F-actin foci at the Ter119 sorting boundary coincident with a cell surface constriction (Figure 1A arrowheads), human erythroblasts exhibit only a few small F-actin foci at the glycophorin A (GPA) sorting boundary, and a cell surface constriction is not observed (Figure 3A, arrowhead).

Moreover, primary human erythroblast nuclei retain their spherical morphology throughout expulsion (Figure 3A), unlike mouse erythroblast nuclei (Figure 1A). This morphology is also observed in histological sections and smears of human bone marrows (supplemental Figure 7). Quantitative image analysis confirmed the lack of cell and nuclear deformation, with the diameter across the GPA sorting boundary and the length of the nucleus along its long axis remaining roughly constant throughout expulsion (Figure 3B-D). Nuclear diameter occupied ∼95% of the GPA sorting boundary diameter throughout expulsion, greater than the ∼75% occupancy observed in mouse erythroblasts (supplemental Table 1), indicating reduced space for cytoskeletal components in human, as compared with mouse erythroblasts, consistent with minimal F-actin staining at the GPA sorting boundary in human erythroblasts (Figure 3A; supplemental movies 4 and 5). Visualization of F-actin at the GPA sorting boundary in 3D reconstructions further revealed F-actin was present in disconnected small foci, inconsistent with formation of a continuous ring during nuclear expulsion (Figure 3F), similar to mouse (Figure 2F).

The differences observed in nuclear shapes adopted by mouse and human enucleating cells imply that mouse erythroblast nuclei may be more deformable than human erythroblast nuclei. Previous studies demonstrated that Lamins play an important role in nuclear stiffness, with increasing Lamin A/C to Lamin B ratio correlating with increased nuclear stiffness.³⁷  We therefore stained mouse and human erythroblasts for Lamin A/C and Lamin B. Mouse enucleating erythroblasts exhibit undetectable Lamin A/C staining, but robust Lamin B staining (Figure 5A). By contrast, human erythroblasts have strong Lamin A/C staining but undetectable Lamin B (Figure 5B), consistent with stiffer nuclei in human erythroblasts and softer, more deformable nuclei in mouse.³⁷ 

The presence of prominent cytoplasmic F-actin/NMIIB/Tmod1 spots that follow the nucleus during expulsion raised the possibility that this F-actin may play a conserved role in nuclear expulsion. First, we used our Tmod1^−/− mouse model, which develops a mild anemia.²⁴  We evaluated terminal erythroid differentiation and enucleation in the FL because the larger-sized erythroblasts (compared with adult) make it easier to evaluate cell morphologies and F-actin organization. Flow cytometry^38,39  demonstrates that erythropoiesis is normal in wild-type and Tmod1^−/− FL cells (Figure 6A-B). Measurement of enucleation in the small subpopulation of Ter119-positive cells (P1)^15,40  identified a small but significant reduction in the percentage of enucleated cells in the Tmod1^−/− FL, indicative of impaired enucleation in the absence of Tmod1 (Figure 6C-E). As control, we examined enucleation in the larger population (P2). Negligible enucleated cells were observed in these wild-type and Tmod1^−/− erythroblasts, precluding premature enucleation (Figure 6C-E).

Confocal microscopy of polarized and enucleating Tmod1^−/− FL erythroblasts indicates that F-actin organization is strikingly abnormal (Figure 6F). In polarized cells, instead of 1 prominent cytoplasmic F-actin spot, there are often several intense F-actin spots located around the nucleus in a nonpolarized fashion (Figure 6F arrows). In enucleating erythroblasts, the cytoplasmic F-actin spot is not always present and often appears in the wrong location near the neck, or over the emerging nuclear protrusion (Figure 6F arrowheads). The nucleus often assumes irregular shapes rather than the dumbbell-shaped morphology typical of wild-type cells. Because Tmod3 can nucleate F-actin assembly,³⁶  and Tmod3 was previously shown to be important for mouse FL erythroblast enucleation,²⁵  we tested whether increased Tmod3 might lead to abnormal F-actin and/or partly compensate for absence of Tmod1. However, Tmod3 levels appeared similar in wild-type and Tmod1^−/− polarized or enucleating erythroblasts (supplemental Figure 6A). Thus, loss of Tmod1 in the mouse leads to abnormal F-actin organization and impaired enucleation.

To assess the function of Tmod1 during human erythroid differentiation, we used lentivirally encoded short hairpin RNAs (shRNAs) to knockdown TMOD1 in CD34⁺ cells differentiating to erythroid cells in culture (Figure 7). Two different shRNAs corresponding to different regions of TMOD1 were used, both efficiently decreasing Tmod1 expression by >80% (Figure 7B-C). Using flow cytometry,²⁶  we observed that TMOD1 knockdown leads to only a slight delay in the terminal stages of differentiation, suggesting a role for TMOD1 in the very late stages (supplemental Figure 8A). We sorted the differentiated cells (supplemental Figure 8B), and using SYTO60 for nuclei, we observed that the absence of TMOD1 severely impairs enucleation (Figure 7D). In TMOD1 knockdown conditions, TMOD3 levels are unchanged (Figure 7C), precluding compensatory mechanisms. Strikingly, TMOD1 knockdown erythroblasts exhibit a considerably greater accumulation of F-actin in the cytoplasmic spot at the rear of the nucleus (Figure 7E-F). This F-actin spot often colocalizes with GPA, suggesting that membrane vesicles may be associated with the abnormal F-actin spot. These observations suggest a new function for Tmod1 in the formation and the regulation of this F-actin spot during enucleation.

Enucleation is a key process of mammalian erythropoiesis and was first observed in 1907 by Jolly.⁴¹  Erythroblast nuclear expulsion has been studied in different species, by a variety of methods,^30,31,42-44  and shares features of asymmetric cell division with the formation of 2 divergent daughter “cells”: an enucleated reticulocyte and a pyrenocyte (expelled nucleus). Observations by Koury et al²⁰  and others^2,11,12,14  that F-actin and NMIIB accumulate at the site of nuclear expulsion also suggested that a contractile ring provides force to expel the nucleus, similar to cytokinesis. Here we tested this model using high-resolution confocal fluorescence microscopy of enucleating primary mouse and human erythroblasts, revealing novel and unexpected details of F-actin and NMIIB organization during nuclear polarization and expulsion (Figure 7G). First, we discovered a novel F-actin structure in the cytoplasm we have named the “enucleosome,” associated with NMIIB and Tmod1, appearing initially in polarized erythroblasts and persisting throughout nuclear expulsion, following along with the rear of the translocating nucleus in both mouse and human erythroblasts. Second, we observed large F-actin/NMIIB foci at the Ter119-sorting boundary during nuclear expulsion in mouse erythroblasts, coinciding with a cell surface constriction and nuclear deformation. In human erythroblasts, a cell surface constriction does not form, the nucleus remains round, and only very small F-actin foci are present at the GPA-sorting boundary. Third, the F-actin foci at the Ter119/GPA-sorting boundary (or neck) do not coalesce into a continuous ring with a decreasing diameter during progression of nuclear expulsion in either mouse or human erythroblasts. Only at the completion of enucleation does F-actin appear to form a small contractile ring-like structure to finally separate the pyrenocyte from the reticulocyte in both mouse and human erythroblasts (Figures 1F and 3F).^11,20 

These data suggest that a contractile ring is unlikely to function in expelling the nucleus. It is also difficult to imagine how constriction of an F-actin contractile ring orthogonal to the direction of nuclear expulsion would provide forces to expel the nucleus, rather than cutting it in half. By contrast, the enucleosome located at the rear of the translocating nucleus is well positioned to exert forces in the direction of nuclear expulsion. This structure could provide force via actin polymerization-based mechanisms directly pushing on the nucleus, or by actomyosin contractility in the cytoplasm indirectly pushing on the nucleus,⁴⁵  as initially proposed by Wang et al²  for mouse erythroblasts. In addition, F-actin polymerization and actomyosin contractility processes are likely to coordinate with microtubule- and vesicular trafficking-based mechanisms to expel the nucleus.^{2,4,11,16,18,20,46}  Future studies of nuclear expulsion using live cell microscopy and fluorescent-tagged proteins will be required to explore these ideas further.

During enucleation, the nucleus adopts different shapes in human as compared with mouse primary erythroblasts (ie, spherical or dumbbell shapes, respectively), and this characteristic is species specific. Curiously, both dumbbell-shaped and round nuclei can be observed in enucleating erythroblasts derived from CD34⁺ progenitors using in vitro culture systems,²⁹  but not in vivo, as shown here. In mouse erythroblasts, robust accumulation of F-actin and NMIIB at the Ter119-sorting boundary may provide contractile forces that constrict the cell surface and deform the nucleus during expulsion, whereas in human erythroblasts, the low abundance of F-actin and NMIIB at the GPA-sorting boundary may explain both the absence of cell surface constriction and the lack of nuclear deformation. Nuclear stiffness could also contribute to differences in nuclear deformation. Although biomechanical measurements have not been performed for mouse erythroblast nuclei, a useful predictor of erythroid nuclear stiffness is thought to be its Lamin A:B ratio, which increases with nuclear stiffness as observed by Discher and colleagues.³⁷  We observed that mouse erythroblast nuclei exhibit little to no Lamin A signal in immunofluorescence, but show robust Lamin B staining in accordance with previous studies,^37,47  implying a low Lamin A:B ratio, low predicted stiffness, and superior deformability. Although nuclear morphology during enucleation varies in different species, and in vitro cultures,^29-31,42,43  elucidation of a direct role for Lamin A:B ratio awaits functional experiments.

Our observation that the F-actin–capping protein Tmod1 is associated with the enucleosome in mouse and human erythroblasts raised the possibility that Tmod1 could regulate its assembly, providing an approach to evaluate its importance for enucleation. Therefore, we studied effects of Tmod1 knockout or knockdown in mouse and human erythropoiesis using in vivo and in vitro models. In Tmod1^−/− mouse FL erythroblasts, terminal differentiation is not affected, but enucleation is mildly impaired and F-actin organization is strikingly abnormal with extra F-actin spots in incorrect locations. Because Tmod3 is not detected in the enucleosome from wild-type or Tmod1^−/− mice, and Tmod3 levels do not appear increased in Tmod1^−/− erythroblasts, we speculate that the mild inhibition of enucleation in absence of Tmod1 may be due to actin-regulatory factors other than Tmod3, although we cannot rule out partial compensation by Tmod3, as observed in Tmod1^−/− mature erythrocytes.²⁴ Tmod3^−/− FL erythroblasts also present abnormal F-actin organization and impaired enucleation.²⁵  However, Tmod3 may operate via a different molecular mechanism than Tmod1, based on their different subcellular locations and different F-actin abnormalities in their absence.²⁵  On the other hand, because erythropoiesis is abnormal in Tmod3^−/− but not Tmod1^−/− FL erythroblasts, Tmod3 might regulate F-actin before the orthochromatic stage, thereby leading subsequently to enucleation defects.

In human erythroblasts in which TMOD1 levels had been reduced by lentiviral shRNA knockdown, terminal differentiation is also unaffected, but enucleation is dramatically reduced. In addition, in TMOD1-depleted polarized or enucleating erythroblasts, the enucleosome appears larger and brighter than in control cells. Thus, absence of Tmod1 (in mouse) or reduced levels of TMOD1 (in human) leads to dysregulation of F-actin, likely due to impaired capping and increased actin polymerization at pointed ends, which in turn adversely impacts enucleation. The altered organization of the F-actin cytoplasmic spots in the Tmod1 knockout or TMOD1 knockdown conditions strongly suggests a role for the enucleosome in providing forces to expel the nucleus. In human erythroblasts, we can infer that there is no compensation from another Tmod family member, because the levels of TMOD3 (the only other Tmod expressed in the erythroid lineage) are unchanged in the TMOD1 knockdown.

In summary, our study describes the F-actin rearrangements during mouse and human erythroblast enucleation and highlights the presence of the enucleosome, a novel F-actin structure at the rear of the nucleus, enriched in F-Actin, NMIIB, and Tmod1. To our knowledge, such a structure has never been described in primary cells before. We further demonstrate that Tmod1 is necessary for the regulation of F-actin polymerization in the human and mouse enucleosome, thereby controlling enucleation. Future studies will seek to identify the trafficking, attachment/anchorage points, molecular composition, and ultrastructure of the enucleosome.

The authors thank Indira Sahdev and Suzan Durham for their help in obtaining bone marrow samples and Mohandas Narla for scientific discussions and his gift of the Band 3 antibody.

This research was supported by National Heart, Lung, and Blood Institute, National Institutes of Health grants R01-HL083464 (V.M.F.), R01-HL079571 (J.M.L.), and R01-HL134043 (subcontract to L.B.); National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health K99-AR066534 (D.S.G.); National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health R01-DK095112 and R01-DK090554 (S.R.); and by the Pediatric Cancer Foundation (J.M.L. and L.B.). L.B. is the recipient of a St. Baldrick’s Scholar award.

Contribution: R.B.N. and D.S.G. designed and performed research, analyzed data, and wrote the manuscript; J.P. and C.C. performed research, analyzed data, and edited the manuscript; S.R. and J.M.L. analyzed data and edited the manuscript; and L.B. and V.M.F. designed research, analyzed data, and edited the manuscript.

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Correspondence: Velia M. Fowler, Department of Molecular Medicine, The Scripps Research Institute, 10550 N Torrey Pines Rd, MB114, La Jolla, CA 92037; e-mail: velia@scripps.edu; and Lionel Blanc, Laboratory of Developmental Erythropoiesis, The Feinstein Institute for Medical Research, 350 Community Dr, Manhasset, NY 11030; e-mail: lblanc@northwell.edu.